Latest Conference Articles

Tariff Pause Reinforces Uncertainty Among Biopharma Professionals

Tariff Pause Reinforces Uncertainty Among Biopharma Professionals

April 10th 2025

INTERPHEX

Even with, or perhaps because of, the rapidity with which changes in United States policy are developing, many in the bio/pharmaceutical industry are taking a longer view.

INTERPHEX 2025: Preventing Spills in the Manufacturing Process

INTERPHEX 2025: Preventing Spills in the Manufacturing Process

April 8th 2025

INTERPHEX

Joe Bobacher of OPW Engineered Systems spoke with Pharmaceutical Technology® Group at INTERPHEX 2025 about fluid transfer in controlled environments and the importance of guarding against product loss.

INTERPHEX 2025: ‘Breaking Up the Octopus’ of Single-Use Systems

INTERPHEX 2025: ‘Breaking Up the Octopus’ of Single-Use Systems

April 7th 2025

INTERPHEX

As single use becomes more prevalent, end users are looking for more customization, and regulators are refining their rules, says Todd Andrews of CPC in an interview with Pharmaceutical Technology® Group.

INTERPHEX 2025: Advanced Flow Sensor Technologies Enable More Accurate Measurement

INTERPHEX 2025: Advanced Flow Sensor Technologies Enable More Accurate Measurement

April 4th 2025

Michael Franco, global sales director at PSG Biotech, spoke with the PharmTech Group at INTERPHEX 2025 about recent advancements in pharmaceutical flow sensor technology.

INTERPHEX 2025: Advancing Treatments for Ultra-Rare Diseases

INTERPHEX 2025: Advancing Treatments for Ultra-Rare Diseases

April 4th 2025

In part two of Pharmaceutical Technology® Group's discussion with Joe Katakowski, director of Research at the RTW Foundation, the work of organizations like RTW Foundation in promoting the development of treatments for ultra-rare diseases is discussed.

Recapping INTERPHEX 2025: Pharma Looks Toward the Future

Recapping INTERPHEX 2025: Pharma Looks Toward the Future

April 4th 2025

INTERPHEX

The yearly convention in New York City showcased new and emerging technologies and gave participating exhibitors a chance to unveil their strategies for the second half of the 2020s.

INTERPHEX 2025: Challenges in Ultra-Rare Disease Treatment Development

INTERPHEX 2025: Challenges in Ultra-Rare Disease Treatment Development

April 4th 2025

The Pharmaceutical Technology® Group sat down with Joe Katakowski, director of Research at the RTW Foundation about the challenges involved in the development of treatments for ultra-rare diseases.

Pharma 4.0: What are Industry Leaders Prioritizing in the Modernization of Pharmaceutical Manufacturing?

Pharma 4.0: What are Industry Leaders Prioritizing in the Modernization of Pharmaceutical Manufacturing?

April 3rd 2025

The move towards “pharma 4.0” requires a major shift, both ideologically and technologically, to adapt current processes to a framework that will automate much of today’s manufacturing.

INTERPHEX 2025: Industry Initiates Interchangeable Single-Use Assembly Components in Response to COVID-19 Supply-Chain Disruption

INTERPHEX 2025: Industry Initiates Interchangeable Single-Use Assembly Components in Response to COVID-19 Supply-Chain Disruption

April 3rd 2025

Sitting down with the PharmTech Group at INTERPHEX 2025, Nicole Hunter, head of Global WMArchitect at WMFTS, explains the industry initiative around single-use assembly components resulting from supply disruptions caused by the COVID-19 pandemic.

INTERPHEX 2025: Beta Bags and Sterile Manufacturing

INTERPHEX 2025: Beta Bags and Sterile Manufacturing

April 3rd 2025

The Pharmaceutical Technology® Group sat down with Chris Gooding, general manager at CRL Solutions, to learn more about how beta bags assist in the transfer of supplies and equipment into a sterile environment.